ArticleEuropean radiology2025
Development and multicentric validation of GRAVITS (GRavity of Venous Insufficiency in post-Thrombotic Syndrome scoring): a novel imaging scoring system for post-thrombotic syndrome. A study by the French Society of Cardiovascular Imaging.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesA standardized grading system for venous post-thrombotic syndrome (PTS) in cross-sectional imaging is lacking. This study aimed to develop and validate GRAVITS (GRavity of Venous Insufficiency in post-Thrombotic Syndrome scoring), a novel MRI-Venography/CT-Venography-based scoring system for venous obstruction, using a Delphi consensus. MATERIALS AND
methodsThe Delphi consensus involved a survey distributed to 22 experts from the French Society of Cardiovascular Imaging. Data was reviewed and discussed in a consensus meeting, where a structured voting process established the GRAVITS system. A retrospective cohort of 40 PTS patients from three centers was analyzed. Twelve venous imaging specialists evaluated venous sequelae in axial MRV/CTV slices using GRAVITS. Inter-observer reproducibility was measured using Krippendorff's alpha (α) and tested across vein types, imaging types, and vein pathological reference status. Intra-observer reproducibility was measured using weighted Kappa (κ
resultsGRAVITS, defined as an ordinal score with four levels ("A: normal vein" to "D: totally occluded vein"), was evaluated in 851 venous segments (40 patients, median age 43.4, 55% women). Inter-observer reproducibility was substantial (α = 0.607), with the highest reproducibility for the external iliac vein (α = 0.693) and the lowest for the popliteal veins (α = 0.364). TrueFISP and BFFE had the highest reproducibility (α = 0.679), while direct CTV was lower (αK = 0.548). κ
conclusionGRAVITS demonstrated substantial reproducibility and significant correlation with CIVIQ-20, supporting its potential as a reliable tool for grading venous sequelae in PTS. Further validation is warranted to refine its clinical utility. KEY POINTS: Question GRAVITS (GRavity of Venous Insufficiency in post-Thrombotic Syndrome scoring) is a novel MRI/CT-based scoring system developed via Delphi consensus to standardize the assessment of venous obstruction in post-thrombotic syndrome (PTS) patients. Findings The GRAVITS score demonstrated high inter-observer reproducibility, particularly in assessing the external iliac vein, with the best results obtained using MRI TrueFISP and BFFE sequences. Clinical relevance GRAVITS provides a standardized, reproducible scoring system for grading venous obstruction in post-thrombotic syndrome using MRI and CT venography. Its correlation with quality-of-life scores highlights its potential clinical utility in assessing patient impairment and guiding management decisions.
Indexed as
Identifiers
40506636What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.